1‐Deoxynojirimycin Alleviates Osteoporosis via Promoting LRP5 Signaling in Osteoblasts and BMSCs
Phytotherapy Research · 09.11.2026
DOI: 10.1002/ptr.70508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 09.11.2026. Verfasst von Kainong Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, The 111 Project from the Education Ministry of China, The Xinjiang Talent Development Fund.
Abstract (Originalsprache)
Osteoporosis is the most common bone disease worldwide, and natural bioactive products that promote osteogenesis are a therapeutic strategy to prevent osteoporosis. 1‐Deoxynojirimycin (DNJ) is the major bioactive small molecule in mulberry with anti‐diabetic properties, but its effect on osteoporosis treatment remains largely unexplored. This study aims to investigate the effects and underlying mechanisms of DNJ on osteoporosis, with a particular emphasis on its ability to promote osteogenesis pathways. We investigated the bone anabolic ability of DNJ in two well‐recognized osteoporosis models: ovariectomy‐induced and high‐fat diet (HFD)‐induced osteoporosis. DNJ prevented estrogen deficiency and HFD‐induced bone loss, resulting in increased osteoblast number and inhibited osteoclast number, supporting its therapeutic potential for osteoporosis. Consistent with these in vivo results, in vitro experiments showed that DNJ promoted osteogenic differentiation and matrix mineralization of primary BMSCs and osteoblasts without affecting primary osteoclast differentiation. Mechanistic studies revealed that DNJ increased osteoblastic mineralization by directly binding to the extracellular domain of the transmembrane protein LRP5, thus promoting the Wnt/β‐catenin signaling axis to activate the transcription of osteogenesis‐related genes in osteoblasts. Taken together, our study demonstrated that DNJ plays a critical role in activating the LRP5/β‐catenin pathway, suggesting its potential as a candidate for osteoporosis prevention and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
- Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Endocrinology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.
- College of Biological Engineering, Henan University of Technology, Zhengzhou, China.
- Beijing Key Laboratory of Intelligent Nutrition and Kinesiological Assessment, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Robert J Tower, Qian Zhang
Förderung
- National Natural Science Foundation of China
- The 111 Project from the Education Ministry of China
- The Xinjiang Talent Development Fund
- 2115 Talent Development Program of China Agricultural University
- Henan Natural Science Foundation of Excellent Young Scholars
Zitieren
APA
Sun, K., Li, Y., Zhao, K., Xu, J., Tower, R. J., Shen, M., Zhang, W., Xiong, W., Li, K., Li, B., & Zhang, Q. (2026). 1‐Deoxynojirimycin Alleviates Osteoporosis via Promoting LRP5 Signaling in Osteoblasts and BMSCs. Phytotherapy Research. https://doi.org/10.1002/ptr.70508
Vancouver
Sun K, Li Y, Zhao K, Xu J, Tower RJ, Shen M, et al. 1‐Deoxynojirimycin Alleviates Osteoporosis via Promoting LRP5 Signaling in Osteoblasts and BMSCs. Phytotherapy Research. 2026. doi:10.1002/ptr.70508
BibTeX
@article{Sun2026,
author = {Sun, Kainong and Li, Yuru and Zhao, Ke and Xu, Jiayang and Tower, Robert J and Shen, Meng and Zhang, Wanhan and Xiong, Wei and Li, Kai and Li, Bo and Zhang, Qian},
title = {1‐Deoxynojirimycin Alleviates Osteoporosis via Promoting LRP5 Signaling in Osteoblasts and BMSCs},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70508}
}
EUVIMED